Cardiff Oncology (CRDF) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Cardiff Oncology (CRDF) over the last 16 years, with Q3 2025 value amounting to -$111.1 million.
- Cardiff Oncology's Enterprise Value fell 852.84% to -$111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$111.1 million, marking a year-over-year decrease of 852.84%. This contributed to the annual value of -$91.7 million for FY2024, which is 2261.74% down from last year.
- According to the latest figures from Q3 2025, Cardiff Oncology's Enterprise Value is -$111.1 million, which was down 852.84% from -$131.2 million recorded in Q2 2025.
- Cardiff Oncology's Enterprise Value's 5-year high stood at -$60.3 million during Q2 2024, with a 5-year trough of -$140.8 million in Q4 2021.
- Moreover, its 5-year median value for Enterprise Value was -$111.1 million (2025), whereas its average is -$108.1 million.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 125370.98% in 2021, then soared by 3255.02% in 2024.
- Cardiff Oncology's Enterprise Value (Quarter) stood at -$140.8 million in 2021, then rose by 25.25% to -$105.3 million in 2022, then grew by 28.92% to -$74.8 million in 2023, then dropped by 22.62% to -$91.7 million in 2024, then fell by 21.05% to -$111.1 million in 2025.
- Its Enterprise Value stands at -$111.1 million for Q3 2025, versus -$131.2 million for Q2 2025 and -$135.7 million for Q1 2025.